NEW YORK (GenomeWeb News) – By folding genomic information about patients' lung cancer tumors in with other clinical data to inform treatment choice, patients generally exhibited improved survival, researchers from the Clinical Lung Cancer Genome Project and the Network Genomic Medicine reported in Science Translational Medicine today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.